Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Preclinical study of the effect of endocannabinoid compounds on the treatment of sleep disorders
*Corresponding Author:
Copyright: © 2020 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
ZBN Research is engaged in preclinical studies of indications of insomnia and pain relief using novel formulations that include ancillary “entourage” compounds and ligands, combinations of cannabinoids, modified THC analogues and new transdermal and sublingual delivery systems that shorten the time to onset of effects and allow for sustained delivery of formulations. Recent findings from ZBN Research’s preclinical study of the effect of endocannabinoid compounds on the treatment of sleep disorders indicate the effectiveness of its new formulation compared to conventional sleep medications.
